These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 19643665)

  • 1. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
    Vereecke L; Beyaert R; van Loo G
    Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
    Yamaguchi N; Yamaguchi N
    FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
    Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
    Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
    Verstrepen L; Carpentier I; Verhelst K; Beyaert R
    Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.
    Frenzel LP; Claus R; Plume N; Schwamb J; Konermann C; Pallasch CP; Claasen J; Brinker R; Wollnik B; Plass C; Wendtner CM
    Int J Cancer; 2011 May; 128(10):2495-500. PubMed ID: 20669229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20: linking a complex regulator of ubiquitylation to immunity and human disease.
    Ma A; Malynn BA
    Nat Rev Immunol; 2012 Nov; 12(11):774-85. PubMed ID: 23059429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20: central gatekeeper in inflammation and immunity.
    Coornaert B; Carpentier I; Beyaert R
    J Biol Chem; 2009 Mar; 284(13):8217-21. PubMed ID: 19008218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
    Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
    Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20 in inflammation and autoimmunity.
    Catrysse L; Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2014 Jan; 35(1):22-31. PubMed ID: 24246475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection.
    Liuwantara D; Elliot M; Smith MW; Yam AO; Walters SN; Marino E; McShea A; Grey ST
    Diabetes; 2006 Sep; 55(9):2491-501. PubMed ID: 16936197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent inactivation of A20 in B-cell lymphomas.
    Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
    Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune regulation role of A20 and its clinical significance].
    Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.